Bacillus anthracis


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Bacillus anthracis - a species of bacillus that causes anthrax in humans and in animals (cattle and swine and sheep and rabbits and mice and guinea pigs)Bacillus anthracis - a species of bacillus that causes anthrax in humans and in animals (cattle and swine and sheep and rabbits and mice and guinea pigs); can be used a bioweapon
B, bacillus - aerobic rod-shaped spore-producing bacterium; often occurring in chainlike formations; found primarily in soil
bioarm, biological weapon, bioweapon - any weapon usable in biological warfare; "they feared use of the smallpox virus as a bioweapon"
References in periodicals archive ?
Microscopic examination of meat revealed gram-positive bacilli, and Bacillus anthracis was evident in the culture growth.
Agents that pose a particularly high risk to humans are classified as Tier 1 Select Agents; Bacillus anthracis is a Tier 1 Select Agent.
Anthrax is a rare but serious illness caused by a spore-forming bacterium called bacillus anthracis. It mainly affects livestock and wild game.
AV7909 is being developed for post-exposure prophylaxis of disease resulting from suspected or confirmed Bacillus anthracis exposure.
Using a grid-based sampling strategy, soil samples (n=1985) were collected from villages (n = 397, 5 samples/village) and examined for Bacillus anthracis, using real time PCR assays.
Anthrax is an infection caused by the bacterium Bacillus anthracis. It can occur in four forms: skin, lungs, intestinal, and injection.
Five strains suspected to be Bacillus anthracis were collected from one of the five patients as well as from soil samples from this epidemic.
The recommendations to the committee sought to optimize the use of Anthrax Vaccine Adsorbed (AVA) in postexposure prophylaxis (PEP) in the event of a wide-area release of Bacillus anthracis spores.
The company said the US FDA approved ANTHIM is indicated in adult and paediatric patients for the treatment of inhalational anthrax due to Bacillus anthracis in combination with antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
In the United States, Bacillus anthracis is a select agent and is subject to select agent requirements under the U.S.
These findings were suggestive of Bacillus anthracis. Finally, PCR was positive for the genes encoding the Protective Antigen (PA) and also capsular region (CAP) confirming Bacillus anthracis in all patients.
Understanding and controlling the spread of Bacillus anthracis, the bacterial agent causing anthrax, in this environment is currently impeded by a lack of data on the genetic diversity and appropriate typing schemes to resolve fine-scale genetic differences.